logo

Terns Pharmaceuticals Inc (TERN) Stock: 52-Week Performance Insights and Trading Volume

ALXO Stock

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Terns Pharmaceuticals Inc’s current trading price is -66.75% away from its 52-week high, while its distance from the 52-week low is 43.25%. The stock’s price range for this time frame has been between $3.26 and $14.04. The trading volume of the company’s shares in the Healthcare reached around 0.66 million for the day, which was evidently lower than the average daily volume of 0.9 million over the last three months.

The market performance of Terns Pharmaceuticals Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $14.04 on 04/20/23, with the lowest value for the same timeframe being $3.26, recorded on 11/10/23.

How Financial Performance Impacts Market Capitalization

Terns Pharmaceuticals Inc (TERN) has experienced a quarterly decline of -19.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 301.92M and boasts a workforce of 66 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.22, with a change in price of +0.92. Similarly, Terns Pharmaceuticals Inc recorded 785,463 in trading volume during the last 100 days, posting a change of +24.53%.

How TERN’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TERN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

TERN Stock Stochastic Average

Terns Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 0.25%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 0.37%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 5.09% and 4.80%, respectively.

TERN Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -28.04%. However, over the past six months, we’ve seen a stronger performance of -11.89%. The price of TERN leaped by -35.14% over the last 30 days. And in the last five days, it has fallen by -15.70%.